Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 64, Issue 5, Pages -
Publisher
American Society for Microbiology
Online
2020-04-20
DOI
10.1128/aac.02074-19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997–2016
- (2019) Michael A Pfaller et al. Open Forum Infectious Diseases
- 615. Daptomycin (DAP) Synergy with β-Lactams in DAP-Resistant (DAP-R) E. faecium (Efm) Is Dependent On PBP5 Sequence and β-Lactam-binding Affinity
- (2019) Ayesha Khan et al. Open Forum Infectious Diseases
- Efficacy of Daptomycin Monotherapy and In Combination with β-lactams for Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions: Influence of The Inoculum Effect
- (2018) Razieh Kebriaei et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSA
- (2018) Ketki Bhise et al. Materials
- Pharmacodynamic Analysis of Daptomycin-Treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint
- (2018) Lindsay M Avery et al. CLINICAL INFECTIOUS DISEASES
- Resistance to β-lactams in enterococci
- (2018) Paula Gagetti et al. REVISTA ARGENTINA DE MICROBIOLOGIA
- Two Mutations Commonly Associated with Daptomycin Resistance in Enterococcus faecium LiaST120A and LiaRW73C Appear To Function Epistatically in LiaFSR Signaling
- (2018) Milya Davlieva et al. BIOCHEMISTRY
- Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs)
- (2017) Juwon Yim et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence
- (2017) Juwon Yim et al. PHARMACOTHERAPY
- An Adaptive Mutation in Enterococcus faecium LiaR Associated with Antimicrobial Peptide Resistance Mimics Phosphorylation and Stabilizes LiaR in an Activated State
- (2016) Milya Davlieva et al. JOURNAL OF MOLECULAR BIOLOGY
- In VitroActivity of Daptomycin in Combination with β-Lactams, Gentamicin, Rifampin, and Tigecycline against Daptomycin-Nonsusceptible Enterococci
- (2015) Janet A. Hindler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multiple Roles for Enterococcus faecalis Glycosyltransferases in Biofilm-Associated Antibiotic Resistance, Cell Envelope Integrity, and Conjugative Transfer
- (2015) Jennifer L. Dale et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2015) Katie E. Barber et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- -Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium
- (2015) J. R. Smith et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Whole-Genome Analyses of Enterococcus faecium Isolates with Diverse Daptomycin MICs
- (2014) Lorena Diaz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Defining Daptomycin Resistance Prevention Exposures in Vancomycin-Resistant Enterococcus faecium and E. faecalis
- (2014) B. J. Werth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanisms of antibiotic resistance in enterococci
- (2014) William R Miller et al. Expert Review of Anti-Infective Therapy
- A liaR Deletion Restores Susceptibility to Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis
- (2014) Jinnethe Reyes et al. JOURNAL OF INFECTIOUS DISEASES
- AliaFCodon Deletion Abolishes Daptomycin Bactericidal Activity against Vancomycin-Resistant Enterococcus faecalis
- (2013) Jose M. Munita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Ceftaroline Activity against Heteroresistant Vancomycin-Intermediate Staphylococcus aureus and Vancomycin-Intermediate Methicillin-Resistant S. aureus Strains in anIn VitroPharmacokinetic/Pharmacodynamic Model: Exploring the “Seesaw Effect”
- (2013) Brian J. Werth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faecium
- (2013) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of High-Level Gentamicin-Resistant Enterococcus faecalis Endocarditis with Daptomycin plus Ceftaroline
- (2013) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin: The role of high-dose and combination therapy for Gram-positive infections
- (2013) Ian M. Gould et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Endocarditis Caused by Resistant Enterococcus: An Overview
- (2013) Katherine Reyes et al. Current Infectious Disease Reports
- Evaluation of Standard- and High-Dose Daptomycin versus Linezolid against Vancomycin-Resistant Enterococcus Isolates in anIn VitroPharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations
- (2012) Ashley D. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biochemical Characterization of Cardiolipin Synthase Mutations Associated with Daptomycin Resistance in Enterococci
- (2012) Milya Davlieva et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Addition of Ceftaroline to Daptomycin after Emergence of Daptomycin-Nonsusceptible Staphylococcus aureus during Therapy Improves Antibacterial Activity
- (2012) Warren E. Rose et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model
- (2012) Brian J. Werth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlation between Mutations inliaFSRof Enterococcus faecium and MIC of Daptomycin: Revisiting Daptomycin Breakpoints
- (2012) Jose M. Munita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America
- (2012) D. R. Osmon et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
- (2012) Dawn M. Sievert et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistantStaphylococcus aureus: case report and review of the literature
- (2012) D.T. Levy et al. Transplant Infectious Disease
- Characterizing Vancomycin-Resistant Enterococcus Strains with Various Mechanisms of Daptomycin Resistance Developed in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2011) Molly E. Steed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Staphylococcus aureus requires cardiolipin for survival under conditions of high salinity
- (2011) Melody Tsai et al. BMC MICROBIOLOGY
- Use of Antistaphylococcal -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding
- (2011) A. Dhand et al. CLINICAL INFECTIOUS DISEASES
- Current Concepts in Antimicrobial Therapy Against Select Gram-Positive Organisms: Methicillin-ResistantStaphylococcus aureus, Penicillin-Resistant Pneumococci, and Vancomycin-Resistant Enterococci
- (2011) Ana Maria Rivera et al. MAYO CLINIC PROCEEDINGS
- Activities of High-Dose Daptomycin, Vancomycin, and Moxifloxacin Alone or in Combination with Clarithromycin or Rifampin in a Novel In Vitro Model of Staphylococcus aureus Biofilm
- (2010) J. Parra-Ruiz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Health Care–Associated Invasive MRSA Infections, 2005-2008
- (2010) Alexander J. Kallen JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Daptomycin Rapidly Penetrates a Staphylococcus epidermidis Biofilm
- (2009) P. S. Stewart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of Daptomycin and Vancomycin Alone and in Combination with Rifampin and Gentamicin against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Isolates in an Experimental Model of Endocarditis
- (2009) K. L. LaPlante et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search